FDA widens role for statins in US

23 February 2010 | by Daniel Williams Print this article Comments Share this article
The makers of rosuvastatin are likely to try to broaden its indication in Australia in line with regulatory changes in the US....

Want to read complete article? Please Sign in or Register.

Recent comments

Most viewed articles this week

Related sites